Department of Rehabilitation Science and Health Technology, Faculty of Health Science, OsloMet - Oslo Metropolitan University, Oslo, Norway.
Research and Communication Unit for Musculoskeletal Health (FORMI), Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
Eur J Pain. 2024 Oct;28(9):1559-1570. doi: 10.1002/ejp.2281. Epub 2024 May 16.
The predictive validity of the STarT Back screening tool among older adults is uncertain. This study aimed to assess the predictive validity of the SBT among older adults in primary care.
This prospective cohort study included 452 patients aged ≥55 years seeking Norwegian primary care with a new episode of back pain. A poor outcome (persistent disabling back pain) was defined as a score of ≥7/24 on the Roland-Morris Disability Questionnaire (RMDQ) at 3, 6 or 12 months of follow-up. The ability of the SBT risk groups to identify persistent disabling back pain was assessed with multivariable logistic regression, area under receiver operating characteristics curve (AUC), and with the accuracy measures sensitivity, specificity, predictive values and likelihood ratios.
The adjusted odds ratios (95% CI) for persistent disabling back pain were 2.40 (1.34-4.30) at 3 months, 3.42 (1.76-6.67) at 6 months and 2.81 (1.47-5.38) at 12 months for the medium-risk group (n = 118), and 8.90 (1.83-43.24), 2.66 (0.81-8.67) and 4.53 (1.24-16.46) for the high-risk group (n = 27), compared to the low-risk group (n = 282). There were no statistically significant differences in odds between the medium- and high-risk groups at any time point. AUC values (95% CI) were 0.65 (0.59-0.71), 0.67 (0.60-0.73) and 0.65 (0.58-0.71) at 3, 6 and 12 months. Accuracy measures were poor at all time points, with particularly poor sensitivity and negative likelihood ratio values.
The predictive validity of the SBT risk groups in predicting persistent disabling back pain in older adults was poor.
This study found that the STarT Back screening tool had poor predictive validity among older adults and that it may need recalibration or extension before widespread implementation among older adults. Having valid tools for this population may aid clinicians with allocating scarce healthcare resources, which is especially important considering the rapidly ageing population and its expected challenge to the healthcare systems.
STarT Back 筛查工具在老年人中的预测效度尚不确定。本研究旨在评估 SBT 在初级保健中老年患者中的预测效度。
这是一项前瞻性队列研究,纳入了 452 名年龄≥55 岁、因新发腰痛前往挪威初级保健的患者。不良结局(持续性致残性腰痛)定义为 3、6 和 12 个月随访时 Roland-Morris 残疾问卷(RMDQ)评分≥7/24。使用多变量逻辑回归、受试者工作特征曲线下面积(AUC)以及准确性指标(敏感性、特异性、预测值和似然比)评估 SBT 风险组识别持续性致残性腰痛的能力。
在 3 个月、6 个月和 12 个月时,中危组(n=118)持续性致残性腰痛的校正比值比(95%CI)分别为 2.40(1.34-4.30)、3.42(1.76-6.67)和 2.81(1.47-5.38),高危组(n=27)分别为 8.90(1.83-43.24)、2.66(0.81-8.67)和 4.53(1.24-16.46),与低危组(n=282)相比。在任何时间点,中危组和高危组之间的比值比均无统计学差异。3、6 和 12 个月时 AUC 值(95%CI)分别为 0.65(0.59-0.71)、0.67(0.60-0.73)和 0.65(0.58-0.71)。所有时间点的准确性指标均较差,尤其是敏感性和阴性似然比较差。
SBT 风险组预测老年人持续性致残性腰痛的预测效度较差。
本研究发现,STarT Back 筛查工具在老年人中的预测效度较差,在广泛应用于老年人之前,可能需要重新校准或扩展。为该人群提供有效的工具可能有助于临床医生分配稀缺的医疗资源,考虑到人口的快速老龄化及其对医疗系统的预期挑战,这一点尤为重要。